Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elixinol Wellness ( (AU:EXL) ) has issued an update.
Elixinol Wellness has scheduled its Annual General Meeting for 27 May 2026, where the re-election of directors will be on the agenda and further details will be provided to shareholders in a forthcoming notice. The company has also set 8 April 2026 as the deadline for receipt of director nominations, signaling the start of a formal governance process that may shape the future composition of its board and oversight of its global wellness operations.
The AGM notice will be made available via the ASX announcements platform and the company’s website, providing investors with standard disclosure around meeting logistics and resolutions. While the announcement is procedural in nature, it underscores ongoing corporate governance activity at Elixinol Wellness as it continues to manage its hemp-based and plant-derived product portfolio across key international markets.
The most recent analyst rating on (AU:EXL) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Elixinol Wellness stock, see the AU:EXL Stock Forecast page.
More about Elixinol Wellness
Elixinol Wellness Limited is a global health and wellness company that develops, markets, and sells hemp and other plant-derived food, skincare, and nutraceutical products. Operating vertically integrated businesses in Australia and the U.S., it produces, manufactures, and distributes nutrition, wellness, and superfood ingredients under brands such as Hemp Foods Australia, The Healthy Chef, Mt Elephant, and The Australian Superfood Co through grocery, wholesale, and e-commerce channels.
Average Trading Volume: 867,962
Technical Sentiment Signal: Sell
Current Market Cap: A$2.9M
Learn more about EXL stock on TipRanks’ Stock Analysis page.